Horizon Pharma Inc (HZNP) 16.84 $HZNP
Horizon Pharma submits IND for go-ahead to start FA Phase 3
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
HZNP: 16.84 (-0.41)
Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma
PR Newswire - Fri Feb 13, 7:45AM CST
Editor Note: For more information about this release, please scroll to bottom.
VRX: 167.00 (-0.50), MDCO: 29.79 (+0.91), HZNP: 16.84 (-0.41), SLXP: 152.35 (+3.17), HSP: 87.35 (unch), VRX.TO: 207.95 (-1.47)
Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Marketwired - Fri Feb 13, 7:00AM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for ACTIMMUNE in the treatment of Friedreich's Ataxia (FA). The Company has simultaneously requested Fast Track Designation.
HZNP: 16.84 (-0.41)
Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST
MNK: 115.01 (+2.51), FLXN: 21.29 (+0.28), XENE: 16.37 (+0.17), HZNP: 16.84 (-0.41), AMPE: 5.85 (-0.05), CBYL: (), ANIK: 41.30 (-0.17)
Horizon Pharma plc Announces Issuance of VIMOVO(R) Related Patent with Protection to 2031 from United States Patent and Trademark Office
Marketwired - Wed Feb 04, 3:06PM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, announced today the issuance of a patent from the United States Patent and Trademark Office (USPTO) entitled "Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer" that relates to the use of VIMOVO(R) (naproxen/esomeprazole magnesium) in patients taking low dose aspirin.
HZNP: 16.84 (-0.41)
POZEN Announces Issuance of VIMOVO(R) Related Patent by the United States Patent and Trademark Office
Business Wire - Wed Feb 04, 3:06PM CST
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced the issuance of a patent by the United States Patent and Trademark Office (USPTO) entitled "Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer" that relates to VIMOVO(R) (naproxen/esomeprazole magnesium) delayed release tablets in patients taking low dose aspirin. The patent expires in October 2031.
HZNP: 16.84 (-0.41), POZN: 6.95 (+0.15)
Flexion patient dosing underway in lead product study
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:27PM CST
MNK: 115.01 (+2.51), FLXN: 21.29 (+0.28), XENE: 16.37 (+0.17), HZNP: 16.84 (-0.41), AMPE: 5.85 (-0.05), CBYL: (), ANIK: 41.30 (-0.17)
Horizon Pharma plc to Participate in Two Conferences in February
Marketwired - Thu Jan 29, 3:05PM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the following conferences in February.
HZNP: 16.84 (-0.41)
Horizon Pharma reports February 27
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 7:31AM CST
HZNP: 16.84 (-0.41)
Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015
Marketwired - Wed Jan 28, 7:01AM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, announced today that its fourth quarter 2014 financial results will be released on Friday, February 27, 2015. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.
HZNP: 16.84 (-0.41)
Invest In Winners, Not Whiners - Cramer's Mad Money (1/27/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Jan 28, 6:33AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, January 27. Cramer started the show by complaining about constant whining by CEOs of companies. He is tired of everyone talking about currency headwinds. He was...
MMM: 165.94 (+0.03), GE: 25.15 (+0.26), HON: 104.38 (+0.88), UTX: 121.25 (+1.66), KMB: 111.00 (+0.82), AKS: 4.87 (+0.39), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), SBUX: 91.58 (-0.24), YHOO: 44.42 (+0.50), DNKN: 46.70 (-0.69), CMI: 139.04 (+2.41), SSYS: 67.16 (-0.34), HZNP: 16.84 (-0.41), COST: 147.10 (-0.66), CAT: 85.13 (+1.60), MSFT: 43.87 (+0.78), AAPL: 127.08 (+0.62), BHI: 64.31 (+1.93), PII: 156.00 (+1.89), SWKS: 81.85 (-0.57), AVT: 45.30 (+0.45), PFE: 34.64 (-0.23), SAM: 303.26 (-0.97), UL: 43.03 (-0.17), HPQ: 38.56 (+0.19), NFLX: 466.10 (+9.37), JWN: 79.41 (+0.04), CVS: 102.63 (-0.37), PG: 85.90 (-0.13), CVX: 112.78 (+1.92)
Jim Cramer's Top Stock Picks: KR LUV BA PII HZNP
at The Street - Wed Jan 28, 5:00AM CST
Cramer is a big fan of Kroger and Southwest Airlines and thinks Boeing shares are priced by buy.
KR: 72.86 (+0.41), HZNP: 16.84 (-0.41), BA: 149.73 (+1.64), PII: 156.00 (+1.89), LUV: 43.30 (-0.20)
Jim Cramer's 'Mad Money' Recap: Why Own Whiners When You Can Own Winners?
at The Street - Tue Jan 27, 7:18PM CST
Cramer says it's time to throw out the companies blaming the strong dollar for their problems and buy the winners at a great price.
MMLP: 30.17 (+0.19), STT: 76.93 (-0.46), KR: 72.86 (+0.41), SWKS: 81.85 (-0.57), HON: 104.38 (+0.88), KMB: 111.00 (+0.82), FCX: 20.29 (+0.82), SAM: 303.26 (-0.97), BA: 149.73 (+1.64), PEP: 99.13 (-1.14), LUV: 43.30 (-0.20), YHOO: 44.42 (+0.50), DNKN: 46.70 (-0.69), ACHN: 10.89 (-0.20), HZNP: 16.84 (-0.41), COST: 147.10 (-0.66), JWN: 79.41 (+0.04), PG: 85.90 (-0.13), CAT: 85.13 (+1.60), MSFT: 43.87 (+0.78), CVX: 112.78 (+1.92), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), FHN: 14.45 (+0.17), PII: 156.00 (+1.89)
Carbylan Therapeutics on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 12:13PM CST
MNK: 115.01 (+2.51), FLXN: 21.29 (+0.28), XENE: 16.37 (+0.17), HZNP: 16.84 (-0.41), AMPE: 5.85 (-0.05), ANIK: 41.30 (-0.17), CBYL: ()
Insider Trading Alert - IGTE, HZNP And AZZ Traded By Insiders
at The Street - Tue Jan 27, 9:01AM CST
Stocks with insider trader activity include IGTE, HZNP and AZZ
AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), HZNP: 16.84 (-0.41)
Horizon Pharma plc (Nasdaq: HZNP) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Fri Jan 23, 9:00AM CST
What:
HZNP: 16.84 (-0.41), NDAQ: 49.48 (-0.27)
Deckers Is A Long-Term Value Stock - Cramer's Lightning Round (1/21/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Jan 22, 6:33AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, January 21, 2015 Bullish calls: Horizon Pharmaceuticals (NASDAQ: HZNP ): "We like all the pain plays; we think there is room for all of them....
CVR: 33.85 (+0.09), CY: 14.76 (+0.01), RICE: 19.13 (-0.22), S: 5.23 (+0.08), DAL: 44.50 (-0.31), DECK: 77.08 (+0.61), HZNP: 16.84 (-0.41), CSLT: 9.19 (+0.13), SDRL: 12.32 (-0.70), IDTI: 20.56 (-0.38), LUV: 43.30 (-0.20)
'Mad Money' Lightning Round: Keep Sprint for the Long Term
at The Street - Thu Jan 22, 5:00AM CST
Cramer thinks Southwest Airlines is a great stock but SeaDrill LImited has been a disaster.
CY: 14.76 (+0.01), ODFL: 76.25 (+0.96), GBX: 57.22 (-0.59), XEC: 112.01 (+1.04), DECK: 77.08 (+0.61), CSLT: 9.19 (+0.13), SDRL: 12.32 (-0.70), IDTI: 20.56 (-0.38), CVRR: 20.20 (+0.58), LUV: 43.30 (-0.20), RICE: 19.13 (-0.22), S: 5.23 (+0.08), HZNP: 16.84 (-0.41), CRZO: 52.60 (+1.17)
Jim Cramer's 'Mad Money' Recap: Netflix Binge Buying Powered Today's Rally
at The Street - Wed Jan 21, 7:21PM CST
Does a single stock have the power to move the markets? Apparently Netflix does, Cramer says.
72.91 (-0.81), TSLA: 203.77 (+0.89), ODFL: 76.25 (+0.96), MMM: 165.94 (+0.03), BX: 37.40 (+0.49), GBX: 57.22 (-0.59), UNH: 109.44 (-0.40), KMB: 111.00 (+0.82), SDRL: 12.32 (-0.70), CVRR: 20.20 (+0.58), TWX: 83.87 (+0.56), LUV: 43.30 (-0.20), JNJ: 99.62 (+1.18), RICE: 19.13 (-0.22), IBM: 160.40 (+1.88), S: 5.23 (+0.08), HZNP: 16.84 (-0.41), CRZO: 52.60 (+1.17), AAPL: 127.08 (+0.62), UNP: 122.60 (-1.23), CY: 14.76 (+0.01), AMZN: 381.83 (+4.66), GPRO: 45.27 (-0.02), SWKS: 81.85 (-0.57), XEC: 112.01 (+1.04), DECK: 77.08 (+0.61), DIS: 104.17 (+0.59), CSLT: 9.19 (+0.13), MO: 54.76 (-0.78), BMY: 60.04 (+0.56), IDTI: 20.56 (-0.38), PCLN: 1,103.37 (+11.42), NFLX: 466.10 (+9.37), AGEN: 5.03 (-0.01), UA: 73.76 (-0.19), JCP: 8.05 (+0.14), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), SNDK: 82.81 (+0.51), EPD: 34.44 (+0.19), FOLD: 8.36 (-0.11), BABA: 89.05 (+1.95)
Barbarian At The Gate: Horizon Pharma (HZNP)
at The Street - Fri Jan 16, 2:52PM CST
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
HZNP: 16.84 (-0.41)
Horizon Pharma submits IND for go-ahead to start FA Phase 3
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 8:15AM CST
HZNP: 16.84 (-0.41)
Technical Notes Covering Pharma Equities -- Valeant Pharma Intl., Salix Pharma, Medicines, Hospira, and Horizon Pharma
PR Newswire - Fri Feb 13, 7:45AM CST
Editor Note: For more information about this release, please scroll to bottom.
VRX: 167.00 (-0.50), MDCO: 29.79 (+0.91), HZNP: 16.84 (-0.41), SLXP: 152.35 (+3.17), HSP: 87.35 (unch), VRX.TO: 207.95 (-1.47)
Horizon Pharma plc Submits Investigational New Drug Application for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Marketwired - Fri Feb 13, 7:00AM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for ACTIMMUNE in the treatment of Friedreich's Ataxia (FA). The Company has simultaneously requested Fast Track Designation.
HZNP: 16.84 (-0.41)
Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST
MNK: 115.01 (+2.51), FLXN: 21.29 (+0.28), XENE: 16.37 (+0.17), HZNP: 16.84 (-0.41), AMPE: 5.85 (-0.05), CBYL: (), ANIK: 41.30 (-0.17)
Horizon Pharma plc Announces Issuance of VIMOVO(R) Related Patent with Protection to 2031 from United States Patent and Trademark Office
Marketwired - Wed Feb 04, 3:06PM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, announced today the issuance of a patent from the United States Patent and Trademark Office (USPTO) entitled "Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer" that relates to the use of VIMOVO(R) (naproxen/esomeprazole magnesium) in patients taking low dose aspirin.
HZNP: 16.84 (-0.41)
POZEN Announces Issuance of VIMOVO(R) Related Patent by the United States Patent and Trademark Office
Business Wire - Wed Feb 04, 3:06PM CST
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, today announced the issuance of a patent by the United States Patent and Trademark Office (USPTO) entitled "Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer" that relates to VIMOVO(R) (naproxen/esomeprazole magnesium) delayed release tablets in patients taking low dose aspirin. The patent expires in October 2031.
HZNP: 16.84 (-0.41), POZN: 6.95 (+0.15)
Flexion patient dosing underway in lead product study
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 3:27PM CST
MNK: 115.01 (+2.51), FLXN: 21.29 (+0.28), XENE: 16.37 (+0.17), HZNP: 16.84 (-0.41), AMPE: 5.85 (-0.05), CBYL: (), ANIK: 41.30 (-0.17)
Horizon Pharma plc to Participate in Two Conferences in February
Marketwired - Thu Jan 29, 3:05PM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the following conferences in February.
HZNP: 16.84 (-0.41)
Horizon Pharma reports February 27
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 7:31AM CST
HZNP: 16.84 (-0.41)
Horizon Pharma plc to Host Fourth Quarter 2014 Conference Call and Webcast on February 27, 2015
Marketwired - Wed Jan 28, 7:01AM CST
Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs, announced today that its fourth quarter 2014 financial results will be released on Friday, February 27, 2015. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.
HZNP: 16.84 (-0.41)
Invest In Winners, Not Whiners - Cramer's Mad Money (1/27/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Jan 28, 6:33AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, January 27. Cramer started the show by complaining about constant whining by CEOs of companies. He is tired of everyone talking about currency headwinds. He was...
MMM: 165.94 (+0.03), GE: 25.15 (+0.26), HON: 104.38 (+0.88), UTX: 121.25 (+1.66), KMB: 111.00 (+0.82), AKS: 4.87 (+0.39), SLB: 88.38 (+2.42), PEP: 99.13 (-1.14), SBUX: 91.58 (-0.24), YHOO: 44.42 (+0.50), DNKN: 46.70 (-0.69), CMI: 139.04 (+2.41), SSYS: 67.16 (-0.34), HZNP: 16.84 (-0.41), COST: 147.10 (-0.66), CAT: 85.13 (+1.60), MSFT: 43.87 (+0.78), AAPL: 127.08 (+0.62), BHI: 64.31 (+1.93), PII: 156.00 (+1.89), SWKS: 81.85 (-0.57), AVT: 45.30 (+0.45), PFE: 34.64 (-0.23), SAM: 303.26 (-0.97), UL: 43.03 (-0.17), HPQ: 38.56 (+0.19), NFLX: 466.10 (+9.37), JWN: 79.41 (+0.04), CVS: 102.63 (-0.37), PG: 85.90 (-0.13), CVX: 112.78 (+1.92)
Jim Cramer's Top Stock Picks: KR LUV BA PII HZNP
at The Street - Wed Jan 28, 5:00AM CST
Cramer is a big fan of Kroger and Southwest Airlines and thinks Boeing shares are priced by buy.
KR: 72.86 (+0.41), HZNP: 16.84 (-0.41), BA: 149.73 (+1.64), PII: 156.00 (+1.89), LUV: 43.30 (-0.20)
Jim Cramer's 'Mad Money' Recap: Why Own Whiners When You Can Own Winners?
at The Street - Tue Jan 27, 7:18PM CST
Cramer says it's time to throw out the companies blaming the strong dollar for their problems and buy the winners at a great price.
MMLP: 30.17 (+0.19), STT: 76.93 (-0.46), KR: 72.86 (+0.41), SWKS: 81.85 (-0.57), HON: 104.38 (+0.88), KMB: 111.00 (+0.82), FCX: 20.29 (+0.82), SAM: 303.26 (-0.97), BA: 149.73 (+1.64), PEP: 99.13 (-1.14), LUV: 43.30 (-0.20), YHOO: 44.42 (+0.50), DNKN: 46.70 (-0.69), ACHN: 10.89 (-0.20), HZNP: 16.84 (-0.41), COST: 147.10 (-0.66), JWN: 79.41 (+0.04), PG: 85.90 (-0.13), CAT: 85.13 (+1.60), MSFT: 43.87 (+0.78), CVX: 112.78 (+1.92), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), FHN: 14.45 (+0.17), PII: 156.00 (+1.89)
Carbylan Therapeutics on deck for IPO
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 12:13PM CST
MNK: 115.01 (+2.51), FLXN: 21.29 (+0.28), XENE: 16.37 (+0.17), HZNP: 16.84 (-0.41), AMPE: 5.85 (-0.05), ANIK: 41.30 (-0.17), CBYL: ()
Insider Trading Alert - IGTE, HZNP And AZZ Traded By Insiders
at The Street - Tue Jan 27, 9:01AM CST
Stocks with insider trader activity include IGTE, HZNP and AZZ
AZZ: 44.86 (+0.22), IGTE: 39.53 (+0.62), HZNP: 16.84 (-0.41)
Horizon Pharma plc (Nasdaq: HZNP) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Fri Jan 23, 9:00AM CST
What:
HZNP: 16.84 (-0.41), NDAQ: 49.48 (-0.27)
Deckers Is A Long-Term Value Stock - Cramer's Lightning Round (1/21/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Jan 22, 6:33AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, January 21, 2015 Bullish calls: Horizon Pharmaceuticals (NASDAQ: HZNP ): "We like all the pain plays; we think there is room for all of them....
CVR: 33.85 (+0.09), CY: 14.76 (+0.01), RICE: 19.13 (-0.22), S: 5.23 (+0.08), DAL: 44.50 (-0.31), DECK: 77.08 (+0.61), HZNP: 16.84 (-0.41), CSLT: 9.19 (+0.13), SDRL: 12.32 (-0.70), IDTI: 20.56 (-0.38), LUV: 43.30 (-0.20)
'Mad Money' Lightning Round: Keep Sprint for the Long Term
at The Street - Thu Jan 22, 5:00AM CST
Cramer thinks Southwest Airlines is a great stock but SeaDrill LImited has been a disaster.
CY: 14.76 (+0.01), ODFL: 76.25 (+0.96), GBX: 57.22 (-0.59), XEC: 112.01 (+1.04), DECK: 77.08 (+0.61), CSLT: 9.19 (+0.13), SDRL: 12.32 (-0.70), IDTI: 20.56 (-0.38), CVRR: 20.20 (+0.58), LUV: 43.30 (-0.20), RICE: 19.13 (-0.22), S: 5.23 (+0.08), HZNP: 16.84 (-0.41), CRZO: 52.60 (+1.17)
Jim Cramer's 'Mad Money' Recap: Netflix Binge Buying Powered Today's Rally
at The Street - Wed Jan 21, 7:21PM CST
Does a single stock have the power to move the markets? Apparently Netflix does, Cramer says.
72.91 (-0.81), TSLA: 203.77 (+0.89), ODFL: 76.25 (+0.96), MMM: 165.94 (+0.03), BX: 37.40 (+0.49), GBX: 57.22 (-0.59), UNH: 109.44 (-0.40), KMB: 111.00 (+0.82), SDRL: 12.32 (-0.70), CVRR: 20.20 (+0.58), TWX: 83.87 (+0.56), LUV: 43.30 (-0.20), JNJ: 99.62 (+1.18), RICE: 19.13 (-0.22), IBM: 160.40 (+1.88), S: 5.23 (+0.08), HZNP: 16.84 (-0.41), CRZO: 52.60 (+1.17), AAPL: 127.08 (+0.62), UNP: 122.60 (-1.23), CY: 14.76 (+0.01), AMZN: 381.83 (+4.66), GPRO: 45.27 (-0.02), SWKS: 81.85 (-0.57), XEC: 112.01 (+1.04), DECK: 77.08 (+0.61), DIS: 104.17 (+0.59), CSLT: 9.19 (+0.13), MO: 54.76 (-0.78), BMY: 60.04 (+0.56), IDTI: 20.56 (-0.38), PCLN: 1,103.37 (+11.42), NFLX: 466.10 (+9.37), AGEN: 5.03 (-0.01), UA: 73.76 (-0.19), JCP: 8.05 (+0.14), MCD: 95.65 (+0.56), PG: 85.90 (-0.13), SNDK: 82.81 (+0.51), EPD: 34.44 (+0.19), FOLD: 8.36 (-0.11), BABA: 89.05 (+1.95) Barbarian At The Gate: Horizon Pharma (HZNP)
at The Street - Fri Jan 16, 2:52PM CST
Trade-Ideas LLC identified Horizon Pharma (HZNP) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
HZNP: 16.84 (-0.41)
